Professional Summary

Professional Overview

Paulo Nigro is a seasoned business executive with extensive experience in the pharmaceutical, biotechnology, and manufacturing industries. He currently serves as the Co-Founder of MKM Biotech, a leading biotechnology company, where he leverages his deep industry expertise to drive innovation and strategy. Nigro is also a Board Member at Blanver and holds advisory roles at PHP Biotech International Inc. and InConnection Consultoria, further showcasing his broad industry influence.

Experience Summary

Current Roles

Co-Founder, MKM Biotech (2021-01-01 to Present)

• Responsible for setting the strategic vision and overseeing the operational execution of MKM Biotech, a rapidly growing biotechnology company.

• Leverages extensive industry knowledge and network to identify promising opportunities and drive the company's research and development initiatives.

• Plays a key role in securing strategic partnerships and securing funding to fuel the company's growth and expansion.

Board Member, Blanver (2021-12-01 to Present)

• Serves on the board of directors for Blanver, a leading pharmaceutical company, providing strategic guidance and oversight.

• Contributes to the company's long-term planning, decision-making, and risk management processes.

• Leverages his deep understanding of the industry to advise on market trends, regulatory changes, and growth strategies.

Conselheiro e Senior Advisor, PHP Biotech International Inc. (2019-01-01 to Present)

• Provides strategic advisory services to PHP Biotech International Inc., a global biotechnology company, leveraging his extensive industry expertise.

• Collaborates with the executive team to identify new business opportunities, navigate complex regulatory environments, and drive operational improvements.

• Contributes to the company's long-term planning and decision-making processes.

Sócio e Senior Advisor - In Connection Consultoria, InConnection (2015-03-01 to Present)

• Serves as a senior advisor at InConnection Consultoria, a leading management consulting firm, where he provides strategic guidance and industry insights.

• Collaborates with clients across a range of industries, helping them navigate complex challenges and unlock new growth opportunities.

• Leverages his extensive network and deep understanding of industry trends to identify valuable partnerships and strategic initiatives.

Career Progression

Chief Executive Officer, Hospital Sírio-Libanês (2021-11-01 to 2024-11-01)

• Served as the Chief Executive Officer of Hospital Sírio-Libanês, a leading healthcare institution, where he was responsible for overseeing the hospital's operations, strategic planning, and organizational development.

• Implemented innovative initiatives to enhance patient care, improve operational efficiency, and strengthen the hospital's market position.

• Fostered a culture of excellence and innovation, driving the organization to achieve new levels of performance and recognition.

CEO and Board Member, GranBio (2020-02-01 to 2021-04-01)

• Served as the Chief Executive Officer and Board Member of GranBio, a prominent biotechnology company, where he was responsible for leading the company's strategic direction and operational execution.

• Spearheaded the development and commercialization of innovative biofuel and biochemical solutions, contributing to the company's growth and industry impact.

• Navigated complex regulatory environments and forged strategic partnerships to expand the company's global reach and market share.

Global CEO InterCement, InterCement (2018-03-01 to 2019-04-01)

• Served as the Global CEO of InterCement, a multinational cement and construction materials company, where he was responsible for leading the company's global operations and strategic initiatives.

• Drove organizational transformation, optimized operational efficiency, and expanded the company's international footprint, positioning it for long-term success.

• Leveraged his deep industry knowledge and cross-functional expertise to enhance the company's competitiveness and market position.

President & CEO, Aché Laboratórios (2014-11-01 to 2017-12-01)

• Served as the President and Chief Executive Officer of Aché Laboratórios, a prominent pharmaceutical company, where he was responsible for overseeing the company's strategic direction, operational performance, and market expansion.

• Implemented innovative strategies to drive revenue growth, improve operational efficiency, and strengthen the company's brand and market share.

• Fostered a culture of